跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HALDOL DECANOATE haloperidol 150 mg/3 mL (as decanoate) Injection ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
HALDOL DECANOATE haloperidol 150 mg/3 mL (as decanoate) Injection ampoule
Approved
STANDARD
HALDOL DECANOATE haloperidol 150 mg/3 mL (as decanoate) Injection ampoule
Clinect Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
d5578c840ba57f04
Company
Clinect Pty Ltd
Type
Standard
Approval Details
Approval Id
d5578c840ba57f04
Product Name
HALDOL DECANOATE haloperidol 150 mg/3 mL (as decanoate) Injection ampoule
Artg Id
46901
Artg Name
HALDOL DECANOATE haloperidol 150 mg/3 mL (as decanoate) injection ampoule
Sponsor
Clinect Pty Ltd
Company Detail Path
/organization/clinect-pty-ltd
Artg Date
1993-11-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/4d2013947ecf7ff9be2739c0ca5e642c.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/d0e2372b818be853a43a04af4e10f070.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
d5578c840ba57f04
Type
Standard
Back to TGA Approvals